EUVIMEDEUVIMED entdecken
Metaanalyse

Early aspirin withdrawal with P2Y12 inhibitor monotherapy vs. standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a meta-analysis of randomised controlled trials

Albi Mahmud, Mohamed Salah M Ibrahim Mohamed, Leena Mohammed Abdulghani Omar Mohammed Abdulghani, Khadeeja Sirajuddin, Unnimaya Adukkadakath, Aadarsh Kumar Roopeja, Ahsan Waheed Qazi, Sami Mohamed, Eman Ibrahim Elzain Hassan, Mishal Nisar, Mohsin Nawaz, Asim Mehmood und 2 weitere

Archives of Medical Science – Atherosclerotic Diseases · 26.06.2026 · 11 (1) · 111-122

DOI: 10.5114/amsad/222182 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 26.06.2026. Verfasst von Albi Mahmud und 13 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the standard antiplatelet strategy following percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS). Prolonged aspirin exposure, however, increases the risk of bleeding, prompting evaluation of early aspirin discontinuation. Material and Methods We performed a systematic search of RCTs comparing abbreviated DAPT followed by P2Y12 inhibitor monotherapy with DAPT in this population. Six RCTs involving 18,794 patients were included.

Results

This strategy showed no significant difference compared with DAPT in the risk of major adverse cardiac and cerebrovascular events, all-cause death, cardiovascular death, myocardial infarction, and stroke. It was associated with significantly lower risk of clinically relevant bleeding (RR = 0.48), major bleeding (RR = 0.44), and net adverse events (RR = 0.80). However, the risk of stent thrombosis was higher with this strategy (RR = 1.83).

Conclusions

Abbreviated DAPT followed by P2Y12 monotherapy maintains efficacy and lowers bleeding, with increased stent thrombosis risk.

Zitieren

APA

Mahmud, A., Mohamed, M. S. M. I., Abdulghani, L. M. A. O. M., Sirajuddin, K., Adukkadakath, U., Roopeja, A. K., Qazi, A. W., Mohamed, S., Hassan, E. I. E., Nisar, M., Nawaz, M., Mehmood, A., Khaleeq, A., & Zulfiqar, E. (2026). Early aspirin withdrawal with P2Y12 inhibitor monotherapy vs. standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a meta-analysis of randomised controlled trials. Archives of Medical Science – Atherosclerotic Diseases, 11(1), 111-122. https://doi.org/10.5114/amsad/222182

Vancouver

Mahmud A, Mohamed MSMI, Abdulghani LMAOM, Sirajuddin K, Adukkadakath U, Roopeja AK, et al. Early aspirin withdrawal with P2Y12 inhibitor monotherapy vs. standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a meta-analysis of randomised controlled trials. Archives of Medical Science – Atherosclerotic Diseases. 2026;11(1):111-122. doi:10.5114/amsad/222182

BibTeX
@article{Mahmud2026,
  author = {Mahmud, Albi and Mohamed, Mohamed Salah M Ibrahim and Abdulghani, Leena Mohammed Abdulghani Omar Mohammed and Sirajuddin, Khadeeja and Adukkadakath, Unnimaya and Roopeja, Aadarsh Kumar and Qazi, Ahsan Waheed and Mohamed, Sami and Hassan, Eman Ibrahim Elzain and Nisar, Mishal and Nawaz, Mohsin and Mehmood, Asim and Khaleeq, Asim and Zulfiqar, Eeshal},
  title = {Early aspirin withdrawal with P2Y12 inhibitor monotherapy vs. standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a meta-analysis of randomised controlled trials},
  journal = {Archives of Medical Science – Atherosclerotic Diseases},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {111--122},
  doi = {10.5114/amsad/222182}
}
Kostenlos starten →